Additionally, the type of pertussis vaccine for primary vaccination, whole cell or acellular vaccine, is known to have a long-lasting impact on important hallmarks of subsequent Bp-specific CD4+ T-cell immunity in response to recall (reviewed in (Ausiello et al., 2019), recently confirmed by (da Silva Antunes et al., 2021)). This evidence concerns the gene CD4 and pertussis.